Clinical applications of angiogenic therapy

LIke ThisLIke ThisLIke ThisLIke ThisLIke This

More than 30 years after the publication of Folkman's seminal paper, angiogenesis inhibitors and stimulators are becoming powerful new weapons in the armamentarium against cancer. They also have demonstrated great promise in treating a host of other illnesses, including heart disease, eye diseases, and even obesity. Click the appropriate link at left to learn more about the applications of angiogenesis research to the treatment of each disease.

In 2001 a documentary of the bench-to-bedside odyssey of angiogenesis research aired on the PBS series NOVA. It can be viewed by clicking the link in the left navigation.

Request an Appointment

If this is a medical emergency, please dial 9-1-1. This form should not be used in an emergency.

Patient Information
Date of Birth:
Contact Information
Appointment Details
Send RequestIf you do not see the specialty you are looking for, please call us at: 617-355-6000.International visitors should call International Health Services at +1-617-355-5209.
Please complete all required fields

This department is currently not accepting appointment requests online. Please call us at: 617-355-6000. International +1-617-355-6000.

This department is currently not accepting appointment requests online. Please call us at: 617-355-6000. International +1-617-355-6000.

Thank you.

Your request has been successfully submitted

You will be contacted within 1 business day.

If you have questions or would like more information, please call:

617-355-6000 +1-617-355-6000
close
Find a Doctor
Search by Clinician's Last Name or Specialty:
Select by Location:
Search by First Letter of Clinician's Last Name: *ABCDEFGHIJKLMNOPQRSTUVWXYZ
More optionsSearch
Condition & Treatments
Search for a Condition or Treatment:
Show Items Starting With: *ABCDEFGHIJKLMNOPQRSTUVWXYZ
View allSearch
Locations
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”
- Sandra L. Fenwick, President and CEO
Close